Baseline Characteristics of Fabry Disease “Amenable” Migalastat Patients in Argentinian Cohort

Figure 5

Frequency distribution of variables “switch from ERT to migalastat” and “migalastat de novo” in patients classified by gender and phenotype and start criterion treatment. M: males; F: females.

(a)

(b)